Researchers have described the neurodegeneration that occurs in the nervous system of the bowel in Batten disease, a rare and fatal genetic condition. In their latest study, a team showed that gene ...

Researchers at Washington University School of Medicine in St. Louis have described the neurodegeneration that occurs in the ...

Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting ...

E1 enzyme: The ineffective E1 enzyme your cells ... impact the patient's quality of life and survival. Treatment The treatment of VEXAS syndrome primarily focuses on managing inflammation and ...

and there are few effective treatment options for the disease. In a new study, researchers at University of California San Diego School of Medicine have discovered that an enzyme called MICAL2 ...

UC San Diego’s latest study reveals MICAL2 as a critical factor in pancreatic cancer progression, offering new avenues for treatment through targeted therapies that could inhibit this enzyme and slow ...

The drug target of AIs is the enzyme aromatase ... This is the therapeutic principle used in the antihormonal AI treatment of ER-positive postmenopausal breast cancer.

[6] How Treatment Targets Inflammatory Events.As noted, topical metronidazole and certain systemic antibiotics constitute first-line therapy for rosacea. Oral tetracycline, doxycycline, and ...

State Key Laboratory of Chemical Resource Engineering, College of Chemistry, Beijing University of Chemical Technology, Beijing 100029, China ...

We also did not perform molecular assessment during the course of the treatment for levels of inflammatory markers, such as IL-17, IL-22 and IL-23, or TNF-α. The original contributions presented in ...

The multidimensional role of ACE2 (angiotensin-converting enzyme 2) in lung disease and pulmonary hypertension. The global overexpression of ACE2 and its effects on the gut microbiota mediates ...

Thus, a trial of inflammation to guide noninvasive and invasive therapy could revolutionize contemporary cardiovascular practice. Potential trial design for utilization of CRP to allocate medical ...